Skip to main content
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Anti-Inflammatory & Anti-Allergy Agents.

Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Anti-Inflammatory & Anti-Allergy Medicinal Chemistry.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Anti-Inflammatory & Anti-Allergy Agents drug discovery.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents) was previously published as Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 4, 2011

Articles

Favourites:
ADD
Favourites:
ADD

The Immune System of Cancer Patients
pp. 262-274(13)
Authors: Torronteguy, Carolina; Paula Souza e Cristina Bonorino, Ana

Favourites:
ADD

Pro-Inflammatory Cytokines and their Actions on the Metabolic Disturbances Associated with Cancer: Implications in Cachexia
pp. 275-280(6)
Authors: M. Argiles, Josep; Toledo, Miriam; J. Lopez-Soriano, Francisco; Busquets, Silvia

Favourites:
ADD

Metabolic Changes in Cancer Patients
pp. 281-285(5)
Authors: Madeddu, Clelia; Maccio, Antonio; Mantovani, Giovanni

Favourites:
ADD

Oxidative Stress and its Clinical Consequences: Relationship between Diabetes and Cancer
pp. 286-298(13)
Authors: M. Victor, Victor; Hernandez-Mijares, Antonio; Rocha, Milagros

Favourites:
ADD

Inflammation and Anemia
pp. 299-314(16)
Authors: Thein, Mya; B. Ershler, William

Favourites:
ADD

Innovative Treatment Approach for Cancer-Related Cachexia
pp. 315-322(8)
Author: Mantovani, Giovanni

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content